Aduro BioTech Closes on $6.5M
Aduro BioTech Inc. has completed an equity financing of $6.5 million. Details of the round, which came from “current investors” were not disclosed. The company is focused on vaccine platforms for the development of vaccines for cancer, infectious diseases and biodefense.
31 January 2013•2 mins read
